ralwel / iStockphoto.com
13 July 2018BiotechnologyJakob Wested, Timo Minssen, Esther van Zimmeren
Will the EPO’s Enlarged Board hear the Broad’s CRISPR case?
“The Opposition Division’s interpretation of the European Patent Convention (EPC) is inconsistent with treaties designed to harmonise the international patent process, including that of the US and Europe.” This was the rather strong reaction of the Broad Institute (BI) after the European Patent Office’s (EPO) Opposition Division’s (OD) decision to revoke one of its CRISPR patents.
